Insider trades

Catherine M. Engelbert, Director of Royalty Pharma RPRX, has filed 1 purchase and 0 sales on the open market. The latest trade was on 06/05.

Catherine M. Engelbert

Director
First filing
23/01/04
Trades
9 trades
Buys / sales
1 / 0
12-month net buying
No record
Last trade
06/05

Trading activity

Transactions

Trade type
Open-market buy23/04/0323/08/0438 sh$281.03$10,679.14+1.9%